Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q1 2014 · 10-Q
Revenue$54.75K$54.75Kno prior Q1 2013 on file Net Income-$206.91K-$206.91KN/M vs Q1 2013 EPS Diluted$0.00$0.00— vs Q1 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flow-$90,542N/M Margins · derivedGross margin85.4%
Operating margin-416.3%
Net margin-377.9%
ended Mar 31, 2014 · filed May 20, 2014 · 50 d after period end